Why Canopy Growth (TSX:WEED) Is the 1 Weed Stock That Won’t Run Out of Business

The Canopy Growth stock is worth watching after the company reported significant progress during its Q3 fiscal 2020. Over the next 90 days, management will be rightsizing the business and building credibility with all stakeholders.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The cannabis industry had a turbulent 2019, and the majority of the players were not reporting profits. This year, however, you might see only one genuinely competent and strong participant to operate and not run out of business. Canopy Growth (TSX:WEED)(NYSE:CGC), the sector’s bellwether, is back in the saddle.

But is Canopy Growth sure to turn the corner in 2020? The recent earnings surprise indicates that it was able to stop the bleeding. Now, the company has a crack at finally achieving profitability.

Business growth opportunities of a lifetime

New CEO David Klein kicked off the earnings call last February 14, 2020. His said his reason for joining Canopy Growth was because the cannabis market is one of the most exciting business growth opportunities of our lifetime.

The fiscal 2020 third-quarter results were not spectacular, although the company made significant progress. Canopy’s CFO Mike Lee gave the financial highlights, beginning with the 13% growth in total net revenue. Its business was able to generate 34% gross margins before fair-value impacts.

Canopy had a loss of $92 million, which is better than the $156 million loss in the previous quarter. Canada’s recreational marijuana posted a 10% increase due to balanced growth in the company’s B2B and B2C channels. Medical sales saw a 5% quarter-over-quarter increase, including a 3% increase in international medical.

The strategic acquisitions (Storz & Bickel, This Works, and BioSteel) contributed almost 22% to total revenue. Mr. Lee said Canopy Growth will still be facing some headwinds. Management, however, is designing a supply chain and footprint that applies to the market realities today and well into the next couple of years.

Cash rich

Klein admits the road ahead is not going to be an easy one. His topmost priorities are the following: improve Canopy’s connection with consumers, bring more focus and discipline to the organization, and define a very visible path to profitability and positive cash flow.

Being a subordinate company of Constellation Brands is the advantage of Canopy Growth. The new CEO is assuring investors that the company will not run of cash. Also, the way to win in the market is to possess the most-trusted and most-loved brands.

With an industry that is evolving, Canopy sees the need to focus on specific markets and product lines where the company has the legitimate right to win. Another asset waiting to deliver is the vaunted line of beverage products. Canopy’s weed drinks have yet to finish scaling production. Drinkable products are the next big thing.

Beacon of hope

According to Canopy Growth’s new CEO, there is a lot of work to be done. The company is taking steps to reduce costs and right-size the business to produce a healthy margin profile and generate cash in the years ahead.

Canopy is hoping the days of burning cash and disappointing sales are over. David Klein is confident that Canopy can capitalize on the opportunity to create an unassailable global position in cannabis. Analysts are forecasting the price of $26.40 today could soar by 127.27% to $60 in the next 12 months. Keep your fingers crossed.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Constellation Brands.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »